Did you know that more than 360,000 Canadians are dependent on prescription drug opioids today? What is even more concerning is that only approximately a third of this number are actually receiving treatment.
Indivior, a global addiction specialty pharmaceutical company that launched Suboxone in the North American market, is looking to change this. Suboxone is the world’s first buprenorphine-based product for opioid dependence therapy and is recognized by several health authorities around the world as an effective treatment option for opioid use disorder and addiction.
To raise awareness for one of the nation’s leading health concerns and break the stigma surrounding a disease that often goes unnoticed and untreated, ORbeOK.ca, a web resource powered by Indivior, will embark on a cross-Canada tour beginning on May 11, 2016, in Vancouver. Accompanying the tour, ORbeOK.ca spokesman Chris Cull, filmmaker and founder of Inspire by Example as well as a recovering opioid addict, will begin the ORbeOK Ride to Inspire cycle tour across the country to continue the conversation surrounding opioid use disorder. #OrBeOkRideToInspire
With the first stop in Vancouver, ORbeOK is giving BC residents the chance to win a one year gym memebership. Head over to their Twitter page and retweet their Tweet for a chance to win!
How to support Chris Cull’s summer tour
To follow Chris on his tour and support ORbeOK’s Ride to Inspire visit Chris’ GoFundMe page.
Help spread awareness and end the stigma against opioid dependence today!